Case report of FLT3-ITD-positive AML patient 11 years after living donor liver transplantation.
With the increasing number of long-term survivors of living donor liver transplantation, the occurrence of secondary cancer is sometimes reported. Solid tumors such as lymphomas are mainly observed. However, only 8 cases of leukemia have been reported so far. For patients younger than 15 years old, leukemia developed in 4 within 3 years after the liver transplantation, whereas acute lymphoblastic leukemia developed in only 1 patient. This is the first case report of a patient in whom FLT3-ITD-positive acute myeloid leukemia (AML) developed more than 10 years after living donor liver transplantation for congenital biliary atresia. AML developed in a 14-year-old boy 11 years after living donor liver transplantation from his father. The patient received the transplant at the age of 3 years and was treated with tacrolimus and methylprednisolone for transplant rejection. Eleven years posttransplantation, he visited the hospital with general malaise and anemia. Blood tests revealed an elevated white blood cell count of 60,100/μL, and the patient was diagnosed with AML. Chromosome analysis revealed a t(6; 9) (p23 q34) translocation; moreover, genetic testing revealed a FLT3-ITD-positive mutation. We started treatment in accordance with the Tokyo Children's Cancer Study Group AML99 protocol. With chemotherapy treatment, the patient achieved complete remission. After chemotherapy, we performed stem cell transplantation from his father. Other patients were reported in relatively early stages after liver transplantation, but our case was more than 10 years posttransplantation. The association with the onset of congenital bile duct atresia and leukemia is still not clear, but we consider the possibility that long-term immunosuppressive drugs contribute to developing leukemia.
Department of Gastrointestinal and Hepato-Biliary-Pancretic Surgery, Nippon Medical School, Tokyo, Japan. Electronic address: Taniain@nms.ac.jp.
N
N
Taniai
Department of Gastrointestinal and Hepato-Biliary-Pancretic Surgery, Nippon Medical School, Tokyo, Japan.
H
H
Yoshida
Department of Gastrointestinal and Hepato-Biliary-Pancretic Surgery, Nippon Medical School, Tokyo, Japan.
Y
Y
Kawano
Department of Gastrointestinal and Hepato-Biliary-Pancretic Surgery, Nippon Medical School, Tokyo, Japan.
E
E
Uchida
D000293:Adolescent; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000378:metabolism; D016031:Liver Transplantation; D019520:Living Donors; D008297:Male; D051941:fms-Like Tyrosine Kinase 3 / Q000378:metabolism*
C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3